Evidence map›Paper›PMID 34681740›Full record

ArticleInternational journal of molecular sciences2021

Multi-Omics Approach to Mitochondrial DNA Damage in Human Muscle Fibers.

Matthias Elstner, Konrad Olszewski, Holger Prokisch, Thomas Klopstock, Marta Murgia

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. A clinical approach to diagnosis and management of mitochondrial myopathies.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 3 countries.

Matthias ElstnerDepartment of Neurology, Technical University Munich, 81675 Munich, Germany.
Konrad OlszewskiCenter for Addictive Disorders, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, 8001 Zurich, Switzerland.
Holger ProkischInstitute of Human Genetics, Technical University Munich, 81675 Munich, Germany.ORCID 0000-0003-2379-6286
Thomas KlopstockDepartment of Neurology, Friedrich-Baur-Institute, University of Munich, 80336 Munich, Germany.ORCID 0000-0003-2805-4652
Marta MurgiaDepartment of Proteomics a Signal Transduction, Max Planck Institute of Biochemistry, 82352 Martinsried, Germany.ORCID 0000-0001-6244-3358
German Center for Neurodegenerative Diseases · DEHelmholtz Zentrum München · DETechnical University of Munich · DEUniversity of Padua · ITUniversity of Zurich · CH

Funding

Agenzia Spaziale Italiana DC-VUM-2017-006Federal Ministry of Education and Research 01GM1906AFederal Ministry of Education and Research Germany 01GM1920
6 · The paper itself

Abstract

Mitochondrial DNA deletions affect energy metabolism at tissue-specific and cell-specific threshold levels, but the pathophysiological mechanisms determining cell fate remain poorly understood. Chronic progressive external ophthalmoplegia (CPEO) is caused by mtDNA deletions and characterized by a mosaic distribution of muscle fibers with defective cytochrome oxidase (COX) activity, interspersed among fibers with retained functional respiratory chain. We used diagnostic histochemistry to distinguish COX-negative from COX-positive fibers in nine muscle biopsies from CPEO patients and performed laser capture microdissection (LCM) coupled to genome-wide gene expression analysis. To gain molecular insight into the pathogenesis, we applied network and pathway analysis to highlight molecular differences of the COX-positive and COX-negative fiber transcriptome. We then integrated our results with proteomics data that we previously obtained comparing COX-positive and COX-negative fiber sections from three other patients. By virtue of the combination of LCM and a multi-omics approach, we here provide a comprehensive resource to tackle the pathogenic changes leading to progressive respiratory chain deficiency and disease in mitochondrial deletion syndromes. Our data show that COX-negative fibers upregulate transcripts involved in translational elongation and protein synthesis. Furthermore, based on functional annotation analysis, we find that mitochondrial transcripts are the most enriched among those with significantly different expression between COX-positive and COX-negative fibers, indicating that our unbiased large-scale approach resolves the core of the pathogenic changes. Further enrichments include transcripts encoding LIM domain proteins, ubiquitin ligases, proteins involved in RNA turnover, and, interestingly, cell cycle arrest and cell death. These pathways may thus have a functional association to the molecular pathogenesis of the disease. Overall, the transcriptome and proteome show a low degree of correlation in CPEO patients, suggesting a relevant contribution of post-transcriptional mechanisms in shaping this disease phenotype.

Indexed as

DNA, MitochondrialElectron Transport Complex IVFemaleGene Expression ProfilingGene Regulatory NetworksHumansLaser Capture MicrodissectionMaleMitochondria, MuscleMuscle Fibers, SkeletalNADPH DehydrogenaseOphthalmoplegia, Chronic Progressive ExternalProteomicsSuccinate DehydrogenaseDNA, MitochondrialElectron Transport Complex IVNADPH DehydrogenaseNDUFA12 protein, humanSuccinate Dehydrogenasedisease modelsmtDNA deletionsmyopathyproteomicsskeletal muscletranscriptomics

Identifiers

PMID34681740
PMCPMC8537949
OpenAlexW3205676638

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.